CovalX steps into the Chinese market

This agreement draws upon CovalX´s experience as a leader in providing novel tools and unique applications for intact protein-protein interaction and macromolecular analysis, and ASPEC’s strong partnerships and infrastructure within the greater China region.  By using CovalX’s products and services for characterizing macromolecules and protein interactions ASPEC customers will have exclusive access to this unique technology in mainland China, Hong Kong, Macau and Taiwan.

Alexis Nazabal, CEO of CovalX AG, commented: "CovalX has been working to share our products in growing markets throughout the world.  We have seen strong growth for many of our new products, namely our services for protein aggregation and epitope mapping characterization.  With this partnership, CovalX now has a strong presence in the fast growing China regions.  This is an exciting opportunity for CovalX to offer our cutting edge technologies for characterizing protein interactions with such a knowledgeable team of ASPEC.  They have long been known to us as a leading distributor of mass spectrometry based tools and services for the China markets and we are exciting for the opportunity to work together."

Currently manufacturing the third generation of high mass detection systems, the HM3, CovalX´s technology is already well recognized as a unique tool for protein-protein interactions analysis, which includes stoichiometry, biotherapeutic aggregation, epitope mapping and immunocomplex characterization; all key applications for the biotech and pharmaceutical industries.  CovalX also has been greatly expanding its CRO analytics facilities to offer a full range of analytical characterization directly to customers.

ASPEC Technologies Limited is a leading provider of mass spectrometric and proteomics products and supplies to the premier proteomics research centers and mass spectrometry laboratories in China. For years ASPEC has been cultivating relationships with academic and industrial partners throughout China.  ASPEC has been a leading distributor of cutting edge technologies and services in the mass spectrometry and related fields.

“With this strategic collaboration ASPEC strengthens its position as a leader of science and technology products in the greater China markets.  The unique CovalX technologies for characterizing protein interactions fit well into our portfolio of cutting edge products and we are exciting to bring these to the rapidly growing China markets. ” said Charles Liu, Ph.D. – President and CTO of ASPEC Technologies Limited.